Published in J Urol on December 01, 2002
GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. Br J Cancer (2014) 0.98
GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy. Oncotarget (2015) 0.78
The importance of clinical application of molecular biomarkers in bladder cancer detection. Maedica (Buchar) (2010) 0.75
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol (2008) 2.45
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate (2004) 2.09
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol (2007) 1.67
Clinical and genetic aspects of craniofrontonasal syndrome: towards resolving a genetic paradox. Mol Genet Metab (2005) 1.14
Pathobiology and prognosis of chromophobe renal cell carcinoma. Urol Oncol (2008) 1.04
The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function. BMC Med Genet (2010) 0.93
INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling. Cancer Cell Int (2009) 0.84
Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Paediatr (2014) 0.83
Promoter CpG hypermethylation and downregulation of DICE1 expression in prostate cancer. Oncogene (2005) 0.83
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma. BJU Int (2007) 0.82
Potocki-Shaffer deletion encompassing ALX4 in a patient with frontonasal dysplasia phenotype. Am J Med Genet A (2013) 0.82
Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer. Arch Dermatol Res (2004) 0.80
The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy. Am J Med Genet A (2007) 0.79
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer. Onkologie (2005) 0.78
A missense mutation in the coiled-coil motif of the HP1-interacting domain of ATR-X in a family with X-linked mental retardation. Neurogenetics (2005) 0.77
Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations. J Pediatr Endocrinol Metab (2016) 0.76
Greig cephalopolysyndactyly (GCPS) contiguous gene syndrome in a boy with a 14 Mb deletion in region 7p13-14 caused by a paternal balanced insertion (5; 7). Appl Clin Genet (2008) 0.75
Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: a pilot study. J Urol (2003) 0.75
Craniofrontonasal Syndrome: Atrial Septal Defect With a Novel EFNB1 Gene Mutation. Cleft Palate Craniofac J (2014) 0.75
Genetic Variants of DICE1/INTS6 in German Prostate Cancer Families with Linkage to 13q14. Urol Int (2015) 0.75
Covalent chemistry and conformational dynamics of topologically chiral amide-based molecular knots. Chemistry (2003) 0.75
Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma. Onkologie (2008) 0.75